AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2023)
Historic Asset Utilization Ratio for AbCellera Biologics (ABCL) over the last 4 years, with Q3 2024 value amounting to 0.01.
- AbCellera Biologics' Asset Utilization Ratio fell 8020.02% to 0.01 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.01, marking a year-over-year decrease of 8020.02%. This contributed to the annual value of 0.02 for FY2024, which is 1937.28% down from last year.
- Latest data reveals that AbCellera Biologics reported Asset Utilization Ratio of 0.01 as of Q3 2024, which was down 8020.02% from 0.01 recorded in Q2 2024.
- AbCellera Biologics' 5-year Asset Utilization Ratio high stood at 0.4 for Q1 2021, and its period low was 0.01 during Q3 2024.
- Its 4-year average for Asset Utilization Ratio is 0.21, with a median of 0.3 in 2021.
- As far as peak fluctuations go, AbCellera Biologics' Asset Utilization Ratio surged by 419.23% in 2022, and later crashed by 9192.36% in 2023.
- Over the past 4 years, AbCellera Biologics' Asset Utilization Ratio (Quarter) stood at 0.3 in 2021, then rose by 4.19% to 0.31 in 2022, then plummeted by 91.92% to 0.03 in 2023, then plummeted by 74.18% to 0.01 in 2024.
- Its Asset Utilization Ratio was 0.01 in Q3 2024, compared to 0.01 in Q2 2024 and 0.02 in Q1 2024.